Anika Therapeutics, Inc. (ANIK) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
32 WIGGINS AVENUE BEDFORD, MA 01730 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 108,828 | 120,954 | 94,386 | 98,318 | 184,943 | 159,014 | |||
| Cash and cash equivalent | 72,867 | 86,327 | 94,386 | 95,817 | 157,463 | 89,042 | |||
| Short-term investments | 35,961 | 34,627 | 2,501 | 27,480 | 69,972 | ||||
| Receivables | 35,961 | 34,627 | 29,843 | 24,102 | 23,079 | 20,775 | |||
| Inventory, net of allowances, customer advances and progress billings | 46,386 | 39,765 | 36,010 | 46,209 | 21,995 | 21,300 | |||
| Inventory | 46,386 | 39,765 | 36,010 | 46,209 | 21,995 | 21,300 | |||
| Disposal group, including discontinued operation | |||||||||
| Other undisclosed current assets | (27,866) | (25,799) | 8,289 | 8,754 | 4,289 | 1,854 | |||
| Total current assets: | 163,309 | 169,547 | 168,528 | 177,383 | 234,306 | 202,943 | |||
| Noncurrent Assets | |||||||||
| Inventory, Noncurrent | |||||||||
| Operating lease, right-of-use asset | 28,767 | 30,696 | 20,957 | 22,619 | 22,864 | ✕ | |||
| Property, plant and equipment | 46,198 | 48,279 | 47,602 | 50,613 | 50,783 | 54,111 | |||
| Intangible assets, net (including goodwill) | 12,197 | 81,938 | 90,163 | 99,570 | 15,279 | 17,042 | |||
| Goodwill | 7,571 | 7,339 | 7,781 | 8,413 | 7,694 | 7,851 | |||
| Intangible assets, net (excluding goodwill) | 4,626 | 74,599 | 82,382 | 91,157 | 7,585 | 9,191 | |||
| Disposal group, including discontinued operation, noncurrent assets | |||||||||
| Deferred income tax assets | 1,489 | 1,449 | ✕ | ||||||
| Other noncurrent assets | 18,672 | 17,219 | 20,285 | 15,420 | 7,478 | 4,897 | |||
| Other undisclosed noncurrent assets | |||||||||
| Total noncurrent assets: | 107,323 | 179,581 | 179,007 | 188,222 | 96,404 | 76,050 | |||
| TOTAL ASSETS: | 270,632 | 349,128 | 347,535 | 365,605 | 330,710 | 278,993 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 26,562 | 24,842 | 21,805 | 20,763 | 13,955 | 10,196 | |||
| Taxes payable | ✕ | ✕ | ✕ | 385 | |||||
| Employee-related liabilities | ✕ | ✕ | ✕ | 9,523 | 7,345 | 5,830 | 4,446 | ||
| Accounts payable | 9,860 | 9,074 | 7,633 | 8,984 | 3,832 | 3,143 | |||
| Accrued liabilities | 16,702 | 15,768 | 4,649 | 4,434 | 4,293 | 2,222 | |||
| Debt | 148 | ||||||||
| Deferred compensation liability | |||||||||
| Disposal group, including discontinued operation | |||||||||
| Business combination, contingent consideration, liability | 4,315 | 13,090 | |||||||
| Other undisclosed current liabilities | 4,497 | 3,072 | 3,675 | 2,866 | 2,322 | 1,093 | |||
| Total current liabilities: | 31,059 | 27,914 | 29,795 | 36,867 | 16,277 | 11,289 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation: | 19,240 | 20,879 | 21,367 | ||||||
| Liabilities, other than long-term debt | 27,308 | 35,651 | 11,415 | 35,459 | 4,688 | 4,092 | |||
| Deferred tax liabilities, net | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 3,542 | ||
| Deferred income tax liabilities | 6,436 | 10,157 | 11,895 | 4,331 | ✕ | ||||
| Disposal group, including discontinued operation, liabilities | |||||||||
| Other liabilities | 404 | 398 | 1,258 | 1,244 | 357 | 550 | |||
| Operating lease, liability | 26,904 | 28,817 | 19,240 | 20,879 | 21,367 | ✕ | |||
| Business combination, contingent consideration, liability | 22,320 | ||||||||
| Total noncurrent liabilities: | 27,308 | 35,651 | 30,655 | 56,338 | 26,055 | 4,092 | |||
| Total liabilities: | 58,367 | 63,565 | 60,450 | 93,205 | 42,332 | 15,381 | |||
| Equity | |||||||||
| Equity, attributable to parent | 212,265 | 285,563 | 287,085 | 272,400 | 288,378 | 263,612 | |||
| Common stock | 147 | 146 | 144 | 143 | 143 | 142 | |||
| Additional paid in capital | 90,009 | 81,141 | 67,081 | 55,355 | 48,707 | 50,763 | |||
| Accumulated other comprehensive loss | (5,943) | (6,443) | (5,718) | (4,542) | (5,898) | (5,526) | |||
| Retained earnings | 128,052 | 210,719 | 225,578 | 221,444 | 245,426 | 218,233 | |||
| Total equity: | 212,265 | 285,563 | 287,085 | 272,400 | 288,378 | 263,612 | |||
| TOTAL LIABILITIES AND EQUITY: | 270,632 | 349,128 | 347,535 | 365,605 | 330,710 | 278,993 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 166,662 | 156,236 | 147,794 | 130,457 | 114,610 | 105,555 | ||
| Cost of revenue (Cost of Product and Service Sold) | (63,574) | (62,660) | (64,851) | (61,431) | (28,747) | (31,280) | ||
| Gross profit: | 103,088 | 93,576 | 82,943 | 69,026 | 85,863 | 74,275 | ||
| Operating expenses | (190,727) | (112,976) | (101,423) | (126,014) | (51,615) | (52,526) | ||
| Other undisclosed operating income | 21,095 | 28,666 | ||||||
| Operating income (loss): | (87,639) | (19,400) | 2,615 | (28,322) | 34,248 | 21,749 | ||
| Interest and debt expense | (11) | (19) | (25) | |||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (87,639) | (19,411) | 2,596 | (28,347) | 34,248 | 21,749 | ||
| Other undisclosed income (loss) from continuing operations before income taxes | 2,312 | 665 | (169) | (277) | 1,873 | 1,458 | ||
| Income (loss) from continuing operations before income taxes: | (85,327) | (18,746) | 2,427 | (28,624) | 36,121 | 23,207 | ||
| Income tax expense (benefit) | 2,660 | 3,887 | 1,707 | 4,642 | (8,928) | (4,485) | ||
| Income (loss) from continuing operations: | (82,667) | (14,859) | 4,134 | (23,982) | 27,193 | 18,722 | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | 4,134 | (23,982) | 27,193 | 18,722 | |
| Net income (loss): | (82,667) | (14,859) | 4,134 | (23,982) | 27,193 | 18,722 | ||
| Other undisclosed net loss attributable to parent | ||||||||
| Net income (loss) available to common stockholders, diluted: | (82,667) | (14,859) | 4,134 | (23,982) | 27,193 | 18,722 | ||
Comprehensive Income ($ in thousands)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (82,667) | (14,859) | 4,134 | (23,982) | 27,193 | 18,722 | ||
| Other comprehensive income (loss) | 500 | (725) | (1,176) | 1,356 | (372) | (742) | ||
| Comprehensive income (loss): | (82,167) | (15,584) | 2,958 | (22,626) | 26,821 | 17,980 | ||
| Other undisclosed comprehensive loss, net of tax, attributable to parent | ||||||||
| Comprehensive income (loss), net of tax, attributable to parent: | (82,167) | (15,584) | 2,958 | (22,626) | 26,821 | 17,980 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.